Inhibikase Therapeutics, Inc. (IKT) SEC filings
IKT SEC filings moved a median of -0.16% by the close. IKT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the IKT overview →
86 measured IKT SEC filing events.
Where these IKT SEC filings landedvs 86 measured IKT SEC filing reactions
| Middle 50% of IKT SEC filing reactions | -3.57% to +1.99% |
|---|---|
| Median reaction (to close) | -0.16% |
| Measured reactions | 86 |
Point-in-time · zero look-ahead
Half of the 86 IKT SEC filing events with a measured close landed between -3.57% and +1.99%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Inhibikase Therapeutics, For: Sep 08 | SEC filing · Form 8-K | +0.00% | -0.82% | |
| Form 8-K Inhibikase Therapeutics, For: Aug 21 | SEC filing · Form 8-K | -2.02% | -0.40% | |
| Form 10-Q Inhibikase Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.68% | +0.84% | |
| Form 8-K Inhibikase Therapeutics, For: Aug 11 | SEC filing · Form 8-K | +1.68% | +0.84% | |
| Form S-8 Inhibikase Therapeutics, | SEC filing · Form S-8 | +1.68% | +0.84% | |
| Form 8-K Inhibikase Therapeutics, For: Jul 29 | SEC filing · Form 8-K | +2.26% | +3.17% | |
| Form 8-K Inhibikase Therapeutics, For: Jul 23 | SEC filing · Form 8-K | +0.68% | +9.39% | |
| Form 8-K Inhibikase Therapeutics, For: Jul 14 | SEC filing · Form 8-K | -4.27% | +0.00% | |
| Form 8-K Inhibikase Therapeutics, For: Jun 26 | SEC filing · Form 8-K | -0.53% | +2.12% | |
| Form 10-Q Inhibikase Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.79% | +0.53% | |
| Form 8-K Inhibikase Therapeutics, For: May 12 | SEC filing · Form 8-K | +0.79% | +0.53% | |
| Form ARS Inhibikase Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.34% | +2.14% | |
| Form DEF 14A Inhibikase Therapeutics, For: Jun 26 | SEC filing · Form DEF | +1.34% | +2.14% | |
| Form DEFA14A Inhibikase Therapeutics, | SEC filing · Form DEFA14A | +1.34% | +2.14% | |
| Form PRE 14A Inhibikase Therapeutics, For: Jun 26 | SEC filing · Form PRE | -1.64% | -6.70% | |
| Form 8-K Inhibikase Therapeutics, For: Apr 07 | SEC filing · Form 8-K | +0.00% | +1.44% | |
| Form 10-K Inhibikase Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.42% | +1.82% | |
| Form 8-K Inhibikase Therapeutics, For: Mar 26 | SEC filing · Form 8-K | +2.42% | +1.82% | |
| Form S-8 Inhibikase Therapeutics, | SEC filing · Form S-8 | +2.42% | +1.82% | |
| Form 8-K Inhibikase Therapeutics, For: Dec 19 | SEC filing · Form 8-K | +0.00% | -2.92% | |
| Form 8-K Inhibikase Therapeutics, For: Nov 20 | SEC filing · Form 8-K | +0.00% | +4.03% | |
| Form 8-K Inhibikase Therapeutics, For: Nov 20 | SEC filing · Form 8-K | +3.23% | -3.87% | |
| Form 10-Q Inhibikase Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.66% | |
| Form 8-K Inhibikase Therapeutics, For: Nov 14 | SEC filing · Form 8-K | +0.00% | +0.66% | |
| Form 10-Q Inhibikase Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K Inhibikase Therapeutics, For: Aug 14 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Inhibikase Therapeutics, For: Jun 27 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form EFFECT Inhibikase Therapeutics, | SEC filing · Form EFFECT | -1.23% | +19.63% | |
| Form S-3 Inhibikase Therapeutics, | SEC filing · Form S-3 | +0.00% | +0.00% | |
| Form DEFA14A Inhibikase Therapeutics, | SEC filing · Form DEFA14A | +2.37% | -2.10% | |
| Form 10-Q Inhibikase Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.69% | -1.93% | |
| Form 8-K Inhibikase Therapeutics, For: May 14 | SEC filing · Form 8-K | +1.69% | -1.93% | |
| Form ARS Inhibikase Therapeutics, For: Dec 31 | SEC filing · Form ARS | -8.83% | +1.36% | |
| Form DEF 14A Inhibikase Therapeutics, For: Jun 27 | SEC filing · Form DEF | -8.83% | +1.36% | |
| Form DEFA14A Inhibikase Therapeutics, | SEC filing · Form DEFA14A | -8.83% | +1.36% | |
| Form PRE 14A Inhibikase Therapeutics, For: Jun 27 | SEC filing · Form PRE | +4.59% | -4.13% | |
| Form 10-K/A Inhibikase Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.40% | +2.33% | |
| Form 8-K Inhibikase Therapeutics, For: Apr 11 | SEC filing · Form 8-K | +0.00% | -9.91% | |
| Form 10-K Inhibikase Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.21% | -3.38% | |
| Form 8-K Inhibikase Therapeutics, For: Mar 27 | SEC filing · Form 8-K | -0.21% | -3.38% | |
| Form S-8 Inhibikase Therapeutics, | SEC filing · Form S-8 | -0.21% | -3.38% | |
| Form 8-K Inhibikase Therapeutics, For: Feb 21 | SEC filing · Form 8-K | -3.90% | -12.06% | |
| Form 8-K Inhibikase Therapeutics, For: Feb 13 | SEC filing · Form 8-K | +0.88% | +14.04% | |
| Form S-8 Inhibikase Therapeutics, | SEC filing · Form S-8 | +1.51% | +4.96% | |
| Form 8-K Inhibikase Therapeutics, For: Jan 29 | SEC filing · Form 8-K | +13.82% | -11.52% | |
| Form EFFECT Inhibikase Therapeutics, | SEC filing · Form EFFECT | +0.00% | -1.80% | |
| Form S-3 Inhibikase Therapeutics, | SEC filing · Form S-3 | +0.35% | -6.67% | |
| Form 8-K Inhibikase Therapeutics, For: Jan 03 | SEC filing · Form 8-K | +0.00% | -2.77% | |
| Form EFFECT Inhibikase Therapeutics, | SEC filing · Form EFFECT | -1.93% | +20.15% | |
| Form 8-K Inhibikase Therapeutics, For: Dec 02 | SEC filing · Form 8-K | -1.93% | +20.15% | |
| Form S-3/A Inhibikase Therapeutics, | SEC filing · Form S-3 | -1.01% | +3.70% | |
| Form DEF 14A Inhibikase Therapeutics, For: Jan 03 | SEC filing · Form DEF | +0.41% | +2.04% | |
| Form S-3 Inhibikase Therapeutics, | SEC filing · Form S-3 | +0.41% | +2.04% | |
| Form 10-Q Inhibikase Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.41% | -4.07% | |
| Form PRE 14A Inhibikase Therapeutics, For: Jan 03 | SEC filing · Form PRE | +1.34% | -4.01% | |
| Form 8-K Inhibikase Therapeutics, For: Oct 21 | SEC filing · Form 8-K | -3.45% | +3.94% | |
| Form 8-K Inhibikase Therapeutics, For: Oct 09 | SEC filing · Form 8-K | +2.36% | +15.75% | |
| Form 8-K Inhibikase Therapeutics, For: Oct 09 | SEC filing · Form 8-K | +3.29% | -17.11% | |
| Form 10-Q Inhibikase Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | -5.38% | |
| Form 8-K Inhibikase Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +0.00% | -2.24% | |
| Form EFFECT Inhibikase Therapeutics, | SEC filing · Form EFFECT | +0.00% | -2.14% | |
| Form DEFA14A Inhibikase Therapeutics, | SEC filing · Form DEFA14A | +0.00% | -6.99% | |
| Form DEF 14A Inhibikase Therapeutics, For: Aug 05 | SEC filing · Form DEF | — | -4.11% | |
| Form S-1 Inhibikase Therapeutics, | SEC filing · Form S-1 | +0.00% | -4.03% | |
| Form 8-K Inhibikase Therapeutics, For: Jun 07 | SEC filing · Form 8-K | — | -0.31% | |
| Form PRE 14A Inhibikase Therapeutics, For: Aug 05 | SEC filing · Form PRE | — | -0.31% | |
| Form D Inhibikase Therapeutics, | SEC filing · Form D | — | -5.46% | |
| Form 8-K Inhibikase Therapeutics, For: May 20 | SEC filing · Form 8-K | -4.00% | +6.29% | |
| Form 10-Q Inhibikase Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -7.10% | -3.83% | |
| Form RW Inhibikase Therapeutics, | SEC filing · Form RW | -0.63% | +25.95% | |
| Form S-1/A Inhibikase Therapeutics, | SEC filing · Form S-1 | -2.88% | -2.16% | |
| Form 8-K Inhibikase Therapeutics, For: Apr 26 | SEC filing · Form 8-K | +3.57% | -4.54% | |
| Form S-1/A Inhibikase Therapeutics, | SEC filing · Form S-1 | +3.57% | -4.54% | |
| Form ARS Inhibikase Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | -3.64% | |
| Form DEF 14A Inhibikase Therapeutics, For: Jun 07 | SEC filing · Form DEF | +0.00% | -3.64% | |
| Form DEFA14A Inhibikase Therapeutics, | SEC filing · Form DEFA14A | +0.00% | -3.64% | |
| Form S-1/A Inhibikase Therapeutics, | SEC filing · Form S-1 | +3.67% | +2.40% | |
| Form 8-K Inhibikase Therapeutics, For: Apr 18 | SEC filing · Form 8-K | +3.40% | -0.97% | |
| Form S-1 Inhibikase Therapeutics, | SEC filing · Form S-1 | -14.28% | -30.10% | |
| Form PRE 14A Inhibikase Therapeutics, For: Jun 07 | SEC filing · Form PRE | -3.09% | -3.36% | |
| Form 8-K/A Inhibikase Therapeutics, For: Jan 16 | SEC filing · Form 8-K | +0.00% | +0.94% | |
| Form 10-K Inhibikase Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +5.05% | -0.92% | |
| Form 8-K Inhibikase Therapeutics, For: Feb 07 | SEC filing · Form 8-K | -4.06% | +0.37% | |
| Form 8-K Inhibikase Therapeutics, For: Feb 01 | SEC filing · Form 8-K | -3.64% | -2.30% | |
| Form 8-K Inhibikase Therapeutics, For: Jan 16 | SEC filing · Form 8-K | -2.37% | -2.37% | |
| Form 10-Q Inhibikase Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -4.76% | +5.31% |
Keep exploring
More IKT: earnings → · analyst actions → · IKT overview →